Clinical Coverage Policy 11A-17 CAR T-Cell Therapy Revision Effective Oct. 1, 2021
Will cover all U.S. FDA approved CAR T-Cell Therapies when administered per U.S. FDA approved guidelines

Will cover all U.S. FDA approved CAR T-Cell Therapies when administered per U.S. FDA approved guidelines

Effective Oct. 1, 2021, Clinical Coverage Policy 11A-17 CAR T-Cell Therapy will be revised to provide coverage for all U.S. FDA approved CAR T-Cell Therapies when administered per U.S. FDA approved guidelines. Medicaid Direct shall continue to require prior approval (PA) for all U.S. FDA approved CAR T-Cell Therapies. 

The revised policy will be available for review on the Stem Cell Transplant Clinical Coverage Policies page.

Contact

NCTracks Call Center: 800-688-6696

Related Topics: